GEN Exclusives

More »

Feature Articles

More »
Jan 1, 2011 (Vol. 31, No. 1)

Adapting Protein Expression for HT

The Best Genes, Well-Tailored Systems, and Ideal Growth Conditions Essential to Process

  • Methylotrophic Yeast

    Click Image To Enlarge +
    VTU Technology reports that its promoter library allows for tunable optimum protein expression.

    Another empirical strategy starts with a contract research organization like VTU Technology taking a gene that a company wants expressed in high quantities as a secreted protein. The firm then designs a synthetic gene that fits the Pichia pastoris codon usage table, along with other parameters. The gene is then pool-cloned into the methylotrophic yeast, and transformants are screened in 96-well deep-well plates.

    VTU has a library of P. pastoris alcohol oxidase 1 (AOX-1) promoters, which the company’s head of R&D, Roland Weis, Ph.D., thinks is probably the strongest native promoter known in the microbial world. The library was created by Professor Anton Glieder from Graz University of Technology and his colleagues by transcription factor binding site mining, producing variants that allow for a variety of expression patterns. These can be transformed into a set of hosts that, for example, co-express various auxiliary proteins.

    The key is that different proteins have different ideal expression requirements. Some proteins give the best yield when they begin to be expressed earlier than they would with the wild-type AOX-1 promoter, while other genes need to be kept silent longer, explains Dr. Weis.

    “There is often no real rationale behind it, and that means you have to screen different promoter types to see which type best fits the needs of the gene.”

    Using this combinatorial approach, VTU can produce and screen thousands of clones in microscale. The best two or three clones are put directly into a small fermentor. “The one-liter fermentation nicely reflects what will come out later in higher-volume fermentations,” Dr. Weis says.

    A typical yield may be in the 5–15 g/L of folded, post-translationally modified protein. “Pichia hardly secretes any other proteins, so there is hardly anything else in the culture supernatant of Pichia fermentation except your protein (if it works well),” he extols.

    By cutting out intermediary steps like shaker flask cultures, the entire process can reportedly be completed in about six weeks.

    For customers who don’t want to deal with the toxicity and safety concerns of using methanol, VTU has created an analogous AOX-1 promoter system driven by glycerol, Dr. Weis notes. These yeast strains are capable of yielding between 30–70% of the best methanol-responsive strains—“but always far beyond the titers that you can reach with competitors’ systems.”

  • Look Mom, No Cells

    Sometimes getting buckets of protein isn’t as important as getting the right proteins, fast. When working on an analytical scale, researchers can often bypass cloning, transfecting, and cell culture by using in vitro translation (IVT) systems based on bacterial, insect, or mammalian cell lysates.

    With IVT you can pull an aliquot out of the freezer, mix it with template mRNA, and in 90 minutes have a protein that normally takes many days or weeks to produce, explains Peter Bell, Ph.D., director of proteomics R&D at Thermo Fisher Scientific (www.thermo.com). “E. coli, insect, and rabbit systems have been getting progressively closer to making human-like proteins, but they have never been perfect, and the yield and functionality of protein has always been variable.”

    The Thermo Scientific Pierce In Vitro Glycoprotein Expression Kit and In Vitro Protein Expression Kit, introduced about a year ago, are the first to be based on human lysates, Dr. Bell says. “The systems provide human post-translational modifications with a higher yield than some of the competing options,” he adds. To date these have been used to produce many important classes of protein including membrane proteins and kinases.

    The benefits of IVT systems include more than just speed. Proteins that would be toxic to a host cell can be produced in vitro, for example, as can those that might otherwise end up in inclusion bodies and be difficult to purify. IVT may also be used to easily incorporate radioactive or otherwise “unnatural” amino acids, which Dr. Bell says Thermo is currently looking into. As a result of ongoing development efforts, he also expects to launch updated products this calendar year that provide a 10-fold improvement in protein yield.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?